152 research outputs found
Recombinants between Deformed wing virus and Varroa destructor virus-1 may prevail in Varroa destructor-infested honeybee colonies
We have used high-throughput Illumina sequencing to identify novel recombinants between
deformed wing virus (DWV) and Varroa destructor virus-1 (VDV-1), which accumulate to
higher levels than DWV in both honeybees and Varroa destructor mites. The recombinants,
VDV-1VVD and VDV-1DVD, exhibit crossovers between the 5’-untranslated region (5’-UTR),
and/or the regions encoding the structural (capsid) and non-structural viral proteins. This
implies the genomes are modular and that each region may evolve independently, as
demonstrated in human enteroviruses. Individual honeybee pupae were infected with a
mixture of observed recombinants and DWV. The strong correlation between VDV-1DVD
levels in honeybee pupae and the associated mites was observed, suggesting that this
recombinant, with a DWV-derived 5’-UTR and non-structural protein region flanking VDV-
1-derived capsid encoding region, is better adapted to transmission between V. destructor and
honeybees than the parental DWV or a recombinant bearing the VDV-1-derived 5’-UTR
(VDV-1VVD)
Interface states in CoFe2O4 spin-filter tunnel junctions
Spin-filter tunneling is a promising way to generate highly spin-polarized
current, a key component for spintronics applications. In this work we explore
the tunneling conductance across the spin-filter material CoFe2O4 interfaced
with Au electrodes, a geometry which provides nearly perfect lattice matching
at the CoFe2O4/Au(001) interface. Using density functional theory calculations
we demonstrate that interface states play a decisive role in controlling the
transport spin polarization in this tunnel junction. For a realistic CoFe2O4
barrier thickness, we predict a tunneling spin polarization of about -60%. We
show that this value is lower than what is expected based solely on
considerations of the spin-polarized band structure of CoFe2O4, and therefore
that these interface states can play a detrimental role. We argue this is a
rather general feature of ferrimagnetic ferrites and could make an important
impact on spin-filter tunneling applications.Comment: 5 pages, 4 Figures plus 1 page supplemen
Direct Visualization of Laser-Driven Focusing Shock Waves
Cylindrically or spherically focusing shock waves have been of keen interest
for the past several decades. In addition to fundamental study of materials
under extreme conditions, cavitation, and sonoluminescence, focusing shock
waves enable myriad applications including hypervelocity launchers, synthesis
of new materials, production of high-temperature and high-density plasma
fields, and a variety of medical therapies. Applications in controlled
thermonuclear fusion and in the study of the conditions reached in laser fusion
are also of current interest. Here we report on a method for direct real-time
visualization and measurement of laser-driven shock generation, propagation,
and 2D focusing in a sample. The 2D focusing of the shock front is the
consequence of spatial shaping of the laser shock generation pulse into a ring
pattern. A substantial increase of the pressure at the convergence of the
acoustic shock front is observed experimentally and simulated numerically.
Single-shot acquisitions using a streak camera reveal that at the convergence
of the shock wave in liquid water the supersonic speed reaches Mach 6,
corresponding to the multiple gigapascal pressure range 30 GPa
Targeted Deletion of HIF-1α Gene in T Cells Prevents their Inhibition in Hypoxic Inflamed Tissues and Improves Septic Mice Survival
Sepsis patients may die either from an overwhelming systemic immune response and/or from an immunoparalysis-associated lack of anti-bacterial immune defence. We hypothesized that bacterial superantigen-activated T cells may be prevented from contribution into anti-bacterial response due to the inhibition of their effector functions by the hypoxia inducible transcription factor (HIF-1alpha) in inflamed and hypoxic areas.Using the Cre-lox-P-system we generated mice with a T-cell targeted deletion of the HIF-1alpha gene and analysed them in an in vivo model of bacterial sepsis. We show that deletion of the HIF-1alpha gene leads to higher levels of pro-inflammatory cytokines, stronger anti-bacterial effects and much better survival of mice. These effects can be at least partially explained by significantly increased NF-kappaB activation in TCR activated HIF-1 alpha deficient T cells.T cells can be recruited to powerfully contribute to anti-bacterial response if they are relieved from inhibition by HIF-1alpha in inflamed and hypoxic areas. Our experiments uncovered the before unappreciated reserve of anti-bacterial capacity of T cells and suggest novel therapeutic anti-pathogen strategies based on targeted deletion or inhibition of HIF-1 alpha in T cells
From ‘Hellstrom Paradox–to anti-adenosinergic cancer immunotherapy
Cancer therapy by endogenous or adoptively transferred anti-tumor T cells is considered complementary to conventional cancer treatment by surgery, radiotherapy or chemotherapy. However, the scope of promising immunotherapeutic protocols is currently limited because tumors can create a ‘hostile–immunosuppressive microenvironment that prevents their destruction by anti-tumor T cells. There is a possibility to develop better and more effective immunotherapies by inactivating mechanisms that inhibit anti-tumor T cells in the tumor microenvironment and thereby protect cancerous tissues from immune damage. This may be now possible because of the recent demonstration that genetic deletion of immunosuppressive A2A and A2B adenosine receptors (A2AR and A2BR) or their pharmacological inactivation can prevent the inhibition of anti-tumor T cells by the hypoxic tumor microenvironment and as a result facilitate full tumor rejection [Ohta A, Gorelik E, Prasad SJ et al (2006) Proc Natl Acad Sci USA 103(35):13132–3137]. This approach is based on in vivo genetic evidence that A2AR play a critical role in the protection of normal tissues from overactive immune cells in acutely inflamed and hypoxic areas. The observations of much improved T-cell-mediated rejection of tumors in mice with inactivated A2AR strongly suggest that A2AR also protects hypoxic cancerous tissues and that A2AR should be inactivated in order to improve tumor rejection by anti-tumor T cells
Genetic Relationship between Cocirculating Human Enteroviruses Species C
Recombination events between human enteroviruses (HEV) are known to occur frequently and to participate in the evolution of these viruses. In a previous study, we reported the isolation of a panel of viruses belonging to the Human enterovirus species C (HEV-C) that had been cocirculating in a small geographic area of Madagascar in 2002. This panel included type 2 vaccine-derived polioviruses (PV) that had caused several cases of acute flaccid paralysis in humans. Previous partial sequencing of the genome of these HEV-C isolates revealed considerable genetic diversity, mostly due to recombination. In the work presented herein, we carried out a more detailed characterization of the genomes of viruses from this collection. First, we determined the full VP1 sequence of 41 of these isolates of different types. These sequences were compared with those of HEV-C isolates obtained from other countries or in other contexts. The sequences of the Madagascan isolates of a given type formed specific clusters clearly differentiated from those formed by other strains of the same type isolated elsewhere. Second, we sequenced the entire genome of 10 viruses representing most of the lineages present in this panel. All but one of the genomes appeared to be mosaic assemblies of different genomic fragments generated by intra- and intertypic recombination. The location of the breakpoints suggested potential preferred genomic regions for recombination. Our results also suggest that recombination between type HEV-99 and other HEV-C may be quite rare. This first exhaustive genomic analysis of a panel of non-PV HEV-C cocirculating in a small human population highlights the high frequency of inter and intra-typic genetic recombination, constituting a widespread mechanism of genetic plasticity and continually shifting the HEV-C biodiversity
A hepatitis B virus causes chronic infections in equids worldwide
Preclinical testing of novel therapeutics for chronic hepatitis B (CHB) requires suitable animal models. Equids host homologs of hepatitis C virus (HCV). Because coinfections of hepatitis B virus (HBV) and HCV occur in humans, we screened 2,917 specimens from equids from five continents for HBV. We discovered a distinct HBV species (Equid HBV, EqHBV) in 3.2% of donkeys and zebras by PCR and antibodies against EqHBV in 5.4% of donkeys and zebras. Molecular, histopathological, and biochemical analyses revealed that infection patterns of EqHBV resembled those of HBV in humans, including hepatotropism, moderate liver damage, evolutionary stasis, and potential horizontal virus transmission. Naturally infected donkeys showed chronic infections resembling CHB with high viral loads of up to 2.6 × 109 mean copies per milliliter serum for >6 mo and weak antibody responses. Antibodies against Equid HCV were codetected in 26.5% of donkeys seropositive for EqHBV, corroborating susceptibility to both hepatitis viruses. Deltavirus pseudotypes carrying EqHBV surface proteins were unable to infect human cells via the HBV receptor NTCP (Na+/taurocholate cotransporting polypeptide), suggesting alternative viral entry mechanisms. Both HBV and EqHBV deltavirus pseudotypes infected primary horse hepatocytes in vitro, supporting a broad host range for EqHBV among equids and suggesting that horses might be suitable for EqHBV and HBV infections in vivo. Evolutionary analyses suggested that EqHBV originated in Africa several thousand years ago, commensurate with the domestication of donkeys. In sum, EqHBV naturally infects diverse equids and mimics HBV infection patterns. Equids provide a unique opportunity for preclinical testing of novel therapeutics for CHB and to investigate HBV/ HCV interplay upon coinfection
Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy
The induction of sterilizing T-cell responses to tumors is a major goal in the development of T-cell vaccines for treating cancer. Although specific components of anti-viral CD8+ immunity are well characterized, we still lack the ability to mimic viral CD8+ T-cell responses in therapeutic settings for treating cancers. Infection with the picornavirus Theiler's murine encephalomyelitis virus (TMEV) induces a strong sterilizing CD8+ T-cell response. In the absence of sterilizing immunity, the virus causes a persistent infection. We capitalized on the ability of TMEV to induce strong cellular immunity even under conditions of immune deficiency by modifying the virus to evaluate its potential as a T-cell vaccine. The introduction of defined CD8+ T-cell epitopes into the leader sequence of the TMEV genome generates an attenuated vaccine strain that can efficiently drive CD8+ T-cell responses to the targeted antigen. This virus activates T-cells in a manner that is capable of inducing targeted tissue damage and glucose dysregulation in an adoptive T-cell transfer model of diabetes mellitus. As a therapeutic vaccine for the treatment of established melanoma, epitope-modified TMEV can induce strong cytotoxic T-cell responses and promote infiltration of the T-cells into established tumors, ultimately leading to a delay in tumor growth and improved survival of vaccinated animals. We propose that epitope-modified TMEV is an excellent candidate for further development as a human T-cell vaccine for use in immunotherapy
- …